X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with IPCA Labs - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES IPCA LABS ALKEM LABORATORIES/
IPCA LABS
 
P/E (TTM) x - 28.0 - View Chart
P/BV x 6.2 2.1 289.6% View Chart
Dividend Yield % 0.7 0.2 291.3%  

Financials

 ALKEM LABORATORIES   IPCA LABS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
IPCA LABS
Mar-17
ALKEM LABORATORIES/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,589643 247.1%   
Low Rs1,232503 245.0%   
Sales per share (Unadj.) Rs417.5254.4 164.1%  
Earnings per share (Unadj.) Rs56.316.1 350.3%  
Cash flow per share (Unadj.) Rs64.729.8 217.3%  
Dividends per share (Unadj.) Rs12.701.00 1,270.0%  
Dividend yield (eoy) %0.90.2 515.8%  
Book value per share (Unadj.) Rs292.9194.6 150.6%  
Shares outstanding (eoy) m119.57126.20 94.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.3 150.0%   
Avg P/E ratio x25.135.7 70.3%  
P/CF ratio (eoy) x21.819.2 113.3%  
Price / Book Value ratio x4.82.9 163.5%  
Dividend payout %22.66.2 362.5%   
Avg Mkt Cap Rs m168,65372,300 233.3%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m9,1716,960 131.8%   
Avg. sales/employee Rs ThNM2,413.5-  
Avg. wages/employee Rs ThNM523.2-  
Avg. net profit/employee Rs ThNM152.4-  
INCOME DATA
Net Sales Rs m49,91532,106 155.5%  
Other income Rs m1,645226 728.9%   
Total revenues Rs m51,56132,332 159.5%   
Gross profit Rs m8,4824,448 190.7%  
Depreciation Rs m1,0061,730 58.2%   
Interest Rs m671241 278.5%   
Profit before tax Rs m8,4512,703 312.6%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606675 237.9%   
Profit after tax Rs m6,7312,028 331.9%  
Gross profit margin %17.013.9 122.7%  
Effective tax rate %19.025.0 76.1%   
Net profit margin %13.56.3 213.5%  
BALANCE SHEET DATA
Current assets Rs m27,06217,340 156.1%   
Current liabilities Rs m15,3249,559 160.3%   
Net working cap to sales %23.524.2 97.0%  
Current ratio x1.81.8 97.4%  
Inventory Days Days67100 66.3%  
Debtors Days Days4157 72.6%  
Net fixed assets Rs m12,61020,779 60.7%   
Share capital Rs m239252 94.7%   
"Free" reserves Rs m34,49024,499 140.8%   
Net worth Rs m35,02724,553 142.7%   
Long term debt Rs m1,2123,517 34.4%   
Total assets Rs m54,38739,595 137.4%  
Interest coverage x13.612.2 111.3%   
Debt to equity ratio x00.1 24.1%  
Sales to assets ratio x0.90.8 113.2%   
Return on assets %13.65.7 237.5%  
Return on equity %19.28.3 232.7%  
Return on capital %24.910.5 237.0%  
Exports to sales %12.948.6 26.6%   
Imports to sales %3.114.2 21.7%   
Exports (fob) Rs m6,46115,617 41.4%   
Imports (cif) Rs m1,5404,571 33.7%   
Fx inflow Rs m6,56315,617 42.0%   
Fx outflow Rs m3,0125,828 51.7%   
Net fx Rs m3,5529,790 36.3%   
CASH FLOW
From Operations Rs m7,2592,764 262.6%  
From Investments Rs m1,864-1,432 -130.2%  
From Financial Activity Rs m-9,273-1,591 582.7%  
Net Cashflow Rs m-150-259 58.0%  

Share Holding

Indian Promoters % 66.9 45.9 145.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 11.4 290.4%  
FIIs % 0.0 25.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 17.4 -  
Shareholders   68,381 36,892 185.4%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   UNICHEM LAB  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  SUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS